id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-276635-0ciy732e	Nijjer, Sukhjinder Singh	Optimal management of acute coronary syndromes in the era of COVID-19	2020-09-02		.txt	text/plain	4483	279	48	While PPCI remains the treatment of choice for STEMI, the number of COVID-19 cases in Wuhan and Lombardy raised sufficient concerns that thrombolysis should be considered in certain circumstances. Low-risk patients with low Global Registry of Acute Coronary Events (GRACE) scores and small troponin-rises can be stratified, and if appropriate, then early urgent angiography can be considered on an 'outpatient' basis without inpatient stays. The treatment for ACS is well established, and while Key points ► Prompt and early revascularisation, with appropriate personal protective equipment, remains the default treatment approach for patients with acute coronary syndrome in the COVID-19 era. ► Critically unwell patients with ST-elevation myocardial infarction, without onsite catheter lab facilities or too unstable for transfer should be considered for thrombolysis and activation of services for facilitated PCI if necessary. Effect of the COVID-19 pandemic on ST-segment-elevation myocardial infarction presentations and in-hospital outcomes	./cache/cord-276635-0ciy732e.txt	./txt/cord-276635-0ciy732e.txt